Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015

Scott, Colleen; Walusimbi, Simon; Kirenga, Bruce; Joloba, Moses; Winters, Muttamba; Abdunoor, Nyombi; Bain, Rommel; Alexander, Heather; Shinnick, Tom; Toney, Sean; Odeke, Rosemary; Mwangi, Christine; Birabwa, Estella; Dejene, Seyoum; Mugabe, Frank; YaDiul, Mukadi; Cavanaugh, J. Sean

doi:10.15585/mmwr.mm6612a6

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015

Published Date:

Mar 31 2017

Publisher's site:

http://dx.doi.org/10.15585/mmwr.mm6612a6

Source:

MMWR Morb Mortal Wkly Rep. 66(12):339-342.

Language:

English

[PDF-239.31 KB]

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep

Personal Author:

Scott, Colleen ; Walusimbi, Simon ; Kirenga, Bruce ; Joloba, Moses ; Winters, Muttamba ; ... More ▼

Corporate Authors:

Centers for Dsease Control and Prevention (U.S.). Epidemic Intelligence Service. ; Center for Global Health (U.S.). Division of Global HIV and TB. ;

Description:

In 2012, Uganda introduced the use of GeneXpert MTB/RIF (Cepheid, Sunnyvale CA), a sensitive, automated, real-time polymerase chain reaction-based platform for tuberculosis (TB) diagnosis, for programmatic use among children, adults with presumptive human immunodeficiency virus (HIV)-associated TB, and symptomatic persons at risk for rifampicin (RIF)-resistant TB. The effect of using the platform's Xpert MTB/RIF assay on TB care and control was assessed using routinely collected programmatic data; in addition, a retrospective review of district quarterly summaries using abstracted TB register data from purposively selected facilities in the capital city of Kampala was conducted. Case notification rates were calculated and nonparametric statistical methods were used for analysis. No statistically significant differences were observed in case notification rates before and after the Xpert MTB/RIF assay became available, although four of 10 districts demonstrated a statistically significant difference in bacteriologically confirmed TB. Once the GeneXpert MTB/RIF platform is established and refined, a more comprehensive evaluation should be conducted.

Subject:

[+]

Pubmed ID:

28358797

Pubmed Central ID:

PMC5657957

Document Type:

Journal Article

Place as Subject:

Uganda

Collection(s):

Morbidity and Mortality Weekly Report (MMWR)

Main Document Checksum:

[+]

Supporting Files:

mm6612a6.nxml

text/xml

No Related Documents.

You May Also Like:

COVID-19 case surveillance public use data

Corporate Authors:

CDC Case Surveillance Task Force.

Published Date:

November 24, 2020

Source:

COVID-19 Case Surveillance Public Use Data | Data | Centers for Disease Control and Prevention. Retrieved November 8, 2020, from https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf

Series:

Data.CDC.gov

Description:

Updated November 24, 2020Data Provided by CDC Case Surveillance Task ForceCurrently, CDC provides the public with COVID-19 case surveillance data in two ways: an 11 data element public use dataset of the line-listed dataset of all COVID-19 cases shar...

File Type:

[PDF - 388.50 KB]
1 de diciembre : Día Mundial del Sida

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.

Published Date:

November 24, 2020

Series:

Día Mundial del Sida
Detengamos Juntos el VIH
World AIDS Day
Let's Stop HIV Together
Ending the HIV epidemic

Description:

December 1 : World AIDS Day [Spanish]cdc-hiv-library-awareness-wad-2020-promo-instagram-spanish.jpg

File Type:

[JPEG - 630.55 KB]
Developing a wastewater surveillance sampling strategy

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

November 23, 2020

Description:

Updated Nov. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 100.05 KB]
Wastewater surveillance testing methods

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

November 23, 2020

Description:

Updated Nov. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 126.01 KB]
Targeted wastewater surveillance at facilities, institutions, and workplaces

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

November 23, 2020

Description:

Updated Nov. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 81.25 KB]